HIV-associated Kaposi sarcoma: understanding how ART and treatment choices affect outcomes
Official title: Project 2
Funded at Lsu Health Sciences Center · NIH-11623226 · Data updated 2026-11-12
A NIH-funded project is exploring how different treatment strategies for HIV-associated Kaposi sarcoma work for people living with HIV in sub-Saharan Africa and similar settings.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lsu Health Sciences Center NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $101,255 |
| NIH project number | 3U54CA277846-04S2 |
| Project ID | NIH-11623226 on NIH RePORTER |
Who could benefit from this research
✓Could help
People living with HIV who have or are at risk for HIV-associated Kaposi sarcoma, particularly in areas with high KS incidence.
✕Less likely to help
Patients without KS or with advanced, non-HIV-related cancers may not benefit from these specific KS-focused approaches.
What this research studies
This grant focuses on AIDS-related Kaposi sarcoma, a common cancer in people with HIV in parts of Africa. Researchers are using existing ACTG staging criteria to understand how tumor size, immune status, and systemic illness relate to treatment responses. They will examine how antiretroviral therapy alone or with chemotherapy impacts lesions and patient outcomes. The study aims to identify which patients benefit most from each treatment approach and how immune recovery influences cancer control. Results could guide more personalized care for EpKS in high-burden regions.
Why it matters
Potential benefit: Findings could help doctors tailor KS treatment to individual patients, potentially improving response rates and survival.
How similar studies have gone: Prior work shows that ART can control KS in many cases, but responses vary and optimal strategies depend on disease stage and immune status.
Where this research is happening
-
Lsu Health Sciences Center
New Orleans, United States Active
Researchers
- Principal investigator: Ngalamika, Owen — Lsu Health Sciences Center
- Study coordinator: Ngalamika, Owen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.